[ad_1]
GlaxoSmithKline (GSK) announced today that it has received national approval for the new generation combined vaccine (IPV / Hib), which can prevent five pediatric diseases at a time.
Inflix-IPV / Hib is a vaccine that combines a human papilloma virus (Hib) with an intellectual IPV that combines the existing DTPa (diphtheria, tetanus, and pertussis) and polio (polio, IPV) vaccines. The total number of inoculations is halved and the convenience of inoculation is high. It also contains an effective component of pertactin to prevent whooping cough.
Currently, DTaP-IPV / Hib vaccine falls into the category of essential childhood vaccines and is inoculated three times at 2, 4 and 6 month intervals.
GSK Managing Director Lee Gyu-nam said, "I am delighted that the Inferrix brand, which has already been the foundation of pediatric vaccination around the world, is again being provided to Korea." It has a high preventive effect and a high anti-pertussis effect. "
IPL / Hib will be provided to young children, hospitals and pediatric clinics starting in the second half of next year.
[ad_2]
Source link
